<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Before intervention, there were no significant differences between groups regarding the serum levels of CAT (
 <italic class="italic">p</italic> = 0.725), GPx (
 <italic class="italic">p</italic> = 0.751), SOD (
 <italic class="italic">p</italic> = 0.793), and MDA (
 <italic class="italic">p</italic> = 0.835). After intervention, however, with adjusting baseline values, significant differences were observed between groups in terms of CAT (
 <italic class="italic">p</italic> = 0.001), GPx (
 <italic class="italic">p</italic> &lt; 0.001), and SOD (
 <italic class="italic">p</italic> &lt; 0.001) levels except for MDA (
 <italic class="italic">p</italic> = 0.420). In a binary comparison, the CAT levels in group 2 (aMD = 9.0; CI 95% = 1.1–16.9, 
 <italic class="italic">p</italic> = 0.021) and group 3 (aMD = 12.2; CI 95% = 4.5–19.9, 
 <italic class="italic">p</italic> &lt; 0.001), the GPx levels in group 2 (aMD = 986.1; CI 95% = 141.1–1831.1, 
 <italic class="italic">p</italic> = 0.017) and group 3 (aMD = 1781.2; CI 95% = 960.7–2601.8, 
 <italic class="italic">p</italic> &lt; 0.001), and the SOD levels in group 2 (aMD = 55.1; CI 95% = 26.0–84.2, 
 <italic class="italic">p</italic> &lt; 0.001) and group 3 (aMD = 55.9; CI 95% = 27.5–84.2, 
 <italic class="italic">p</italic> &lt; 0.001) significantly increased in comparison with group 1. However, the binary comparison displayed no significant decrease in the MDA levels in group 2 (aMD = −0.1; CI 95% = −0.4 to 0.1, 
 <italic class="italic">p</italic> = 0.502) and group 3 (aMD = −0.1; CI 95% = −0.4 to 0.1, 
 <italic class="italic">p</italic> = 0.725). In addition, the binary comparison indicated no significant difference in the SOD, GPx, CAT, and MDA levels between groups 2 and 3 (
 <italic class="italic">p</italic> &gt; 0.05).
</p>
